Clinical Trials Browser

INDUSTRY × ER+ HER2- Advanced Breast Cancer × AZD9496 × Clear all

NCT02248090 2019-06-24

AZD9496 First Time in Patients Ascending Dose Study

Phase 1 Completed

ER+ HER2- Advanced Breast Cancer